{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:36:22Z","timestamp":1793118982718,"version":"4.5.0"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005799","name":"National Chiao Tung University","doi-asserted-by":"publisher","award":["RD2024-003"],"award-info":[{"award-number":["RD2024-003"]}],"id":[{"id":"10.13039\/501100005799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-A49-022"],"award-info":[{"award-number":["NSTC 113-2314-B-A49-022"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Myopia has been a rising problem globally. Early-onset myopia significantly increases the risk of high myopia later in life. Despite the proven benefits of increased outdoor time, optimal strategies for preventing early-onset myopia in premyopic children need further investigation.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This randomized controlled trial aims to evaluate the efficacy of optical (Defocus Incorporated Multiple Segments [DIMS] spectacle lenses) and pharmacological (0.01% atropine eye drops) interventions in preventing myopia among premyopic preschoolers. We will recruit 234 premyopic, asymptomatic 5-to-6-year-old children who will have received cycloplegic autorefraction examination in a countywide kindergarten eye care program in Yilan County, Taiwan. Eligible participants will be randomly assigned to DIMS spectacles (n = 78), 0.01% atropine (n = 78), or usual care (n = 78). In the DIMS group, preschoolers will be instructed to wear spectacles at home before entering elementary school but to wear them all the time after school entry. In the atropine group, subjects will be given 0.01% atropine eyedrops nightly throughout the study period. All participants will be encouraged to spend time outdoors for 2 hours every day. During the 18-month study period, cycloplegic spherical equivalent (SE) refraction, axial length, and subfoveal choroidal thickness will be measured every three months, and parents-administered questionnaires regarding risk factors for myopia will be performed every nine months.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Primary outcome<\/jats:title>\n<jats:p>The change in mean cycloplegic SE.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Secondary outcomes<\/jats:title>\n<jats:p>The cumulative percentage of incident myopia, the cumulative percentage of a fast myopic shift of SE, and the changes in mean axial length.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Other pre-specified outcomes<\/jats:title>\n<jats:p>The time to myopia onset, alteration in subfoveal choroidal thickness, and levels of near work\/outdoor activities.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec006\">\n<jats:title>Trial registration<\/jats:title>\n<jats:p>This study is registered at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.clinicaltrials.gov\/\" xlink:type=\"simple\">www.clinicaltrials.gov<\/jats:ext-link> as <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT06200194\" xlink:type=\"simple\">NCT06200194<\/jats:ext-link>.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec007\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This trial will provide insights into myopia prevention strategies and inform new eye care policies for early identification and intervention in premyopic preschoolers.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0312935","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T18:45:09Z","timestamp":1735670709000},"page":"e0312935","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of defocus incorporated multiple segments (DIMS) lenses and low-dose atropine on retarding myopic shift among premyopic preschoolers: Protocol for a prospective, multicenter, randomized controlled trial"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5168-8261","authenticated-orcid":true,"given":"Hsin-Yu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2239-1132","authenticated-orcid":true,"given":"Der-Chong","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5774-038X","authenticated-orcid":true,"given":"Yu-Chieh","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Wei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"issue":"5","key":"pone.0312935.ref001","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.survophthal.2017.03.006","article-title":"Myopia among schoolchildren in East Asia and Singapore","volume":"62","author":"BY Ding","year":"2017","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"pone.0312935.ref002","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ophtha.2021.08.013","article-title":"Prevalence Trend of Myopia after Promoting Eye Care in Preschoolers: A Serial Survey in Taiwan before and during the Coronavirus Disease 2019 Pandemic","volume":"129","author":"YC Yang","year":"2022","journal-title":"Ophthalmology"},{"key":"pone.0312935.ref003","unstructured":"Bureau of Health Promotion DoH, Executive Yuan, Republic of China (Taiwan). Bureau of Health Promotion, Department of Health, Executive Yuan, Republic of China (Taiwan). 2023."},{"issue":"11","key":"pone.0312935.ref004","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/jamaophthalmol.2020.3451","article-title":"Association of Age at Myopia Onset With Risk of High Myopia in Adulthood in a 12-Year Follow-up of a Chinese Cohort","volume":"138","author":"Y Hu","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"pone.0312935.ref005","doi-asserted-by":"crossref","first-page":"M1","DOI":"10.1167\/iovs.18-25980","article-title":"IMI\u2013Myopia Control Reports Overview and Introduction.","volume":"60","author":"JS Wolffsohn","year":"2019","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"3","key":"pone.0312935.ref006","doi-asserted-by":"crossref","first-page":"M20","DOI":"10.1167\/iovs.18-25957","article-title":"IMI\u2014Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies","volume":"60","author":"DI Flitcroft","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"pone.0312935.ref007","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1755-3768.2009.01800.x","article-title":"Is emmetropia the natural endpoint for human refractive development? An analysis of population-based data from the refractive error study in children (RESC)","volume":"88","author":"IG Morgan","year":"2010","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"pone.0312935.ref008","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ophtha.2022.03.017","article-title":"Premyopia at Preschool Age: Population-based Evidence of Prevalence and Risk Factors from a Serial Survey in Taiwan","volume":"129","author":"CY Wang","year":"2022","journal-title":"Ophthalmology"},{"issue":"15","key":"pone.0312935.ref009","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1167\/iovs.16-20288","article-title":"Myopia Development Among Young Schoolchildren: The Myopia Investigation Study in Taipei","volume":"57","author":"DC Tsai","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"pone.0312935.ref010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaophthalmol.2015.0471","article-title":"Prediction of Juvenile-Onset Myopia","volume":"133","author":"K Zadnik","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"pone.0312935.ref011","first-page":"e78","article-title":"The prevalence of myopia remains stable under tighter COVID-19 social restriction in preschoolers receiving a school-based eyecare program","volume":"102","author":"YC Yang","year":"2024","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"pone.0312935.ref012","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamaophthalmol.2020.6239","article-title":"Progression of Myopia in School-Aged Children After COVID-19 Home Confinement","volume":"139","author":"J Wang","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"pone.0312935.ref013","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jamaophthalmol.2021.3563","article-title":"Rates of Myopia Development in Young Chinese Schoolchildren During the Outbreak of COVID-19","volume":"139","author":"Y Hu","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"pone.0312935.ref014","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ophtha.2012.11.009","article-title":"Outdoor activity during class recess reduces myopia onset and progression in school children","volume":"120","author":"PC Wu","year":"2013","journal-title":"Ophthalmology"},{"issue":"11","key":"pone.0312935.ref015","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/jama.2015.10803","article-title":"Effect of Time Spent Outdoors at School on the Development of Myopia Among Children in China: A Randomized Clinical Trial","volume":"314","author":"M He","year":"2015","journal-title":"Jama"},{"issue":"12","key":"pone.0312935.ref016","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"WH Chua","year":"2006","journal-title":"Ophthalmology"},{"issue":"2","key":"pone.0312935.ref017","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).","volume":"119","author":"A Chia","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"pone.0312935.ref018","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control","volume":"126","author":"JC Yam","year":"2019","journal-title":"Ophthalmology"},{"issue":"7","key":"pone.0312935.ref019","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","article-title":"Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report","volume":"127","author":"JC Yam","year":"2020","journal-title":"Ophthalmology"},{"issue":"3","key":"pone.0312935.ref020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","article-title":"Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout: Phase 3 Report","volume":"129","author":"JC Yam","year":"2022","journal-title":"Ophthalmology"},{"issue":"14","key":"pone.0312935.ref021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/iovs.61.14.15","article-title":"Effects of Atropine Treatment on Choroidal Thickness in Myopic Children","volume":"61","author":"L Ye","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"pone.0312935.ref022","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ophtha.2021.10.016","article-title":"Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children: A Network Meta-Analysis","volume":"129","author":"A Ha","year":"2022","journal-title":"Ophthalmology"},{"key":"pone.0312935.ref023","doi-asserted-by":"crossref","first-page":"1125000","DOI":"10.3389\/fpubh.2023.1125000","article-title":"Effectiveness of myopia control interventions: A systematic review of 12 randomized control trials published between 2019 and 2021","volume":"11","author":"C Lanca","year":"2023","journal-title":"Front Public Health"},{"issue":"8","key":"pone.0312935.ref024","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.ophtha.2020.12.036","article-title":"Age Effect on Treatment Responses to 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study","volume":"128","author":"FF Li","year":"2021","journal-title":"Ophthalmology"},{"issue":"6","key":"pone.0312935.ref025","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.2022.24162","article-title":"Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial.","volume":"329","author":"JC Yam","year":"2023","journal-title":"JAMA"},{"issue":"8","key":"pone.0312935.ref026","first-page":"1110","article-title":"Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study","volume":"106","author":"CS Lam","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"pone.0312935.ref027","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/ijo.IJO_1462_21","article-title":"Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes","volume":"70","author":"J. Jethani","year":"2022","journal-title":"Indian J Ophthalmol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0312935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T18:45:23Z","timestamp":1735670723000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0312935"}},"subtitle":[],"editor":[{"given":"Nick","family":"Fogt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0312935","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}